Ginkgo Results Presentation Deck

Segment Information (Unaudited) In millions of USD Revenue: Foundry Biosecurity Total Revenue Segment cost of revenue: Biosecurity Segment research and development expense: Foundry Biosecurity Total segment research and development expense Segment general and administrative expense: Foundry Biosecurity Total segment general and administrative expense Segment operating income (loss): Foundry Biosecurity Total segment operating income (loss) Operating expenses not allocated to segments: Stock-based compensation Depreciation and amortization Other Loss from operations Three Months Ended June 30, 2021 % YoY 2022 $44 100 145 64 63 0 63 37 12 49 (55) 24 (32) 607 9 (1) (647) $22 22 44 17 41 4 45 15 5 20 (34) (5) (38) 15 ܢ ܘ 7 0 (60) 105% 355% 231% 274% 54% (90%) 40% 149% 144% 147% (62%) NM 18% NM 34% NM NM Six Months Ended June 30, 2022 2021 % YoY $66 247 313 149 110 1 111 63 26 89 (108) 71 (36) 1,266 19 0 (1,321) $44 44 88 41 49% 467% 257% 72 53% 28 (97%) 99 12% (56) (35) (90) 266% 28 127% 167% 10 37 137% 15 12 0 (117) (94%) NM 60% NM 50% NM NM 39 Property of Ginkgo Bioworks Q2 2022 UPDATE & BUSINESS REVIEW

View entire presentation